Efficacy of the BNT162b2 Vaccine Against Omicron Infection in Children Aged 5 to 11 Years
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age
N. Engl. J. Med 2022 Jun 29;[EPub Ahead of Print], CJ Cohen-Stavi, O Magen, N Barda, S Yaron, A Peretz, D Netzer, C Giaquinto, A Judd, L Leibovici, MA Hernán, M Lipsitch, BY Reis, RD Balicer, N DaganFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.